Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Notes Payables (2025 - 2026)

Updated

Genmab A's Short-Term Borrowings was $294 million in the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Notes Payables (2025 - 2026) Analysis & Trends

As of Dec 31, 2025, Short-Term Borrowings at Genmab A came in at $273 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 318.00
Jun 30, 2026 294.00 Mn
Mar 31, 2026 275.00
Dec 31, 2025 273.00 Mn
API Access

Genmab A Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GMAB&period=max&api_key=YOUR_API_KEY